These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 5554467)

  • 1. Influence of 4,4'-(isopropylidenedithio)bis(2,6-di-t-butylphenol) (DH-581) on experimental atherosclerosis in rabbits.
    Kritchevsky D; Kim HK; Tepper SA
    Proc Soc Exp Biol Med; 1971 Apr; 136(4):1216-21. PubMed ID: 5554467
    [No Abstract]   [Full Text] [Related]  

  • 2. Hypocholesterolemic effect of 4,4'-(isopropylidenedithio)-bis(2,6-di-t-butylphenol) (probucol).
    Barnhart JW; Sefranka JA; McIntosh DD
    Am J Clin Nutr; 1970 Sep; 23(9):1229-33. PubMed ID: 5450842
    [No Abstract]   [Full Text] [Related]  

  • 3. The effect of [4,4'-(isopropylidenethio)bis(2,6-di-t-butylphenol)] (DH-581) on serum lipids and lipoproteins in human subjects.
    Drake JW; Bradford RH; McDearmon M; Furman RH
    Metabolism; 1969 Nov; 18(11):916-25. PubMed ID: 5350556
    [No Abstract]   [Full Text] [Related]  

  • 4. Laboratory studies of 1-methyl-4-piperidyl bis(p-chlorophenoxy) acetate (SaH 42-348)--a new hypolipidemic agent.
    Timms AR; Kelly LA; Ho RS; Trapold JH
    Biochem Pharmacol; 1969 Aug; 18(8):1861-71. PubMed ID: 5811622
    [No Abstract]   [Full Text] [Related]  

  • 5. The effect of nicotinic acid and pentaerythritolteranicotinate upon experimental atherosclerosis in the rabbit.
    Brattsand R; Lundholm L
    Atherosclerosis; 1971; 14(1):91-105. PubMed ID: 5130977
    [No Abstract]   [Full Text] [Related]  

  • 6. The additive effects of clofibrate and probucol (DH-581) on rat serum cholesterol.
    Duncan CH; Best MM
    Atherosclerosis; 1973; 17(2):161-6. PubMed ID: 4709117
    [No Abstract]   [Full Text] [Related]  

  • 7. [Effect of atromide on the endogenously-induced experimental hypercholesteremia and development lipoidosis of the aorta in rabbits].
    Metelitsa VI; Sverdlova PS; Aleksandrov AA; Zakharova MP; Daragan AG
    Kardiologiia; 1970 Sep; 10(9):25-9. PubMed ID: 5501510
    [No Abstract]   [Full Text] [Related]  

  • 8. Long-term oral administration of probucol (4,4'-(isopropylidenedithio) bis(2,6-di-t-butylphenol)) (DH-581) in the management of hypercholesterolemia.
    Harris RS; Gilmore HR; Bricker LA; Kiem IM; Rubin E
    J Am Geriatr Soc; 1974 Apr; 22(4):167-75. PubMed ID: 4594122
    [No Abstract]   [Full Text] [Related]  

  • 9. Influence of ethyl p-chlorophenoxyisobutyrate (CPIB) upon establishment and progression of experimental atherosclerosis in rabbits.
    Kritchevsky D; Sallata P; Tepper SA
    J Atheroscler Res; 1968; 8(5):755-61. PubMed ID: 5688373
    [No Abstract]   [Full Text] [Related]  

  • 10. [Pharmacology of probucol. I].
    Donatelli L
    Clin Ter; 1984 Mar; 108(5):367-88. PubMed ID: 6232074
    [No Abstract]   [Full Text] [Related]  

  • 11. Studies on new nicotinic acid ester derivatives. 6. Serum cholesterol level lowering effect of 2,2,6,6-tetrakis(nicotinoyloxymethyl) cyclohexanol (K-31).
    Aso Y; Abe Y; Higo K; Naruke T; Irikura T
    J Atheroscler Res; 1969; 10(3):391-401. PubMed ID: 5364087
    [No Abstract]   [Full Text] [Related]  

  • 12. Influence of mevinolin on experimental atherosclerosis in rabbits.
    Kritchevsky D; Tepper SA; Klurfeld DM
    Pharmacol Res Commun; 1981 Nov; 13(10):921-6. PubMed ID: 6918018
    [No Abstract]   [Full Text] [Related]  

  • 13. Action of the urinary antisteroid substance in experimental atheromatosis.
    Damian E; Ianăş O; Bădescu I
    Rev Roum Med; 1974; 12(3):185-8. PubMed ID: 4460213
    [No Abstract]   [Full Text] [Related]  

  • 14. Effect of colestipol (U-26,597A) on experimental atherosclerosis in rabbits.
    Kritchevsky D; Kim HK; Tepper SA
    Proc Soc Exp Biol Med; 1973 Jan; 142(1):185-8. PubMed ID: 4683239
    [No Abstract]   [Full Text] [Related]  

  • 15. Suppression of established atherosclerosis and xanthomas in mature WHHL rabbits by keeping their serum cholesterol levels extremely low. Effect of pravastatin sodium in combination with cholestyramine.
    Shiomi M; Ito T; Watanabe Y; Tsujita Y; Kuroda M; Arai M; Fukami M; Fukushige J; Tamura A
    Atherosclerosis; 1990 Jul; 83(1):69-80. PubMed ID: 2117930
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Experimental atherosclerosis with ascorbic acid deficiency.
    Fujinami T; Okado K; Senda K; Sugimura M; Kishikawa M
    Jpn Circ J; 1971 Dec; 35(12):1559-65. PubMed ID: 5172476
    [No Abstract]   [Full Text] [Related]  

  • 17. Phospholipids in experimental atherosclerosis.
    Altman RF; de Mendonça JM; Schaeffer GM; de Souza JR; Bandoli JG; da Silva DJ; Lopes CR
    Arzneimittelforschung; 1974 Jan; 24(1):11-6. PubMed ID: 4406098
    [No Abstract]   [Full Text] [Related]  

  • 18. Effect of the ethyl ester and sodium salt of alpha-p-chlorophenoxyisobutyric acid on cholesterol oxidation by rat liver mitochondria.
    Kritchevsky D; Tepper SA; Sallata P; Kabakjian JR; Cristofalo VJ
    Proc Soc Exp Biol Med; 1969 Oct; 132(1):79-82. PubMed ID: 5344871
    [No Abstract]   [Full Text] [Related]  

  • 19. Severe pulmonary atherosclerosis in hypercholesterolemic rabbits.
    Child GV; Thurlbeck WM; Weigensberg BI
    Arch Pathol; 1974 Jul; 98(1):47-50. PubMed ID: 4829775
    [No Abstract]   [Full Text] [Related]  

  • 20. The effect of elastoproteinase on experimental atheromatosis in rabbits.
    Loeven WA
    Eur J Pharmacol; 1967 May; 1(3):254-61. PubMed ID: 6058910
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.